Ticiana Leal, MD - The Expanding Immunotherapy Frontier in NSCLC: From Established ICI-Based Approaches to the Next Wave of Innovation

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SRR865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.The Expanding Immunotherapy Frontier in NSCLC: From Established ICI-Based Approaches to the Next Wave of Innovation In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Regeneron Pharmaceuticals, Inc., and Summit Therapeutics Inc.Disclosure information is available at the beginning of the video presentation.